PL3604339T3

Therapeutic antibodies against ror-1 protein and methods for use of same

Abstract

This record has no abstract on file.

Term

5.3 yearsto projected expiry

Projected expiry 13 January 2032, counted from filing; an application has no term until it is granted.

  1. Priority
  2. Filed
  3. Published
  4. Today
  5. Projected expiry

41 members in 9 offices

This recordMember, by publication datePriority claim

Priority claims16

Priority claims
DocumentOfficeKindDate
201161433043United States of AmericaP
201161433043United States of AmericaP
12734733European Patent Office (EPO)A
12734733European Patent Office (EPO)A
17167174European Patent Office (EPO)A
17167174European Patent Office (EPO)A
19192973European Patent Office (EPO)A
2012021339United States of AmericaW
2012021339United States of AmericaW
191929736
201161433043P
EP20120734733
EP20170167174
EP20190192973
US201161433043P
WO2012US21339

Members41

Family members, oldest first
DocumentOfficeKind
WO2012097313A2World Intellectual Property Organization (WIPO)A2
WO2012097313A3World Intellectual Property Organization (WIPO)A3
CA2858350A1CanadaA1
CA2981662A1CanadaA1
CA3027071A1CanadaA1
US2013273073A1United States of AmericaA1
EP2663579A2European Patent Office (EPO)A2
EP2663579A4European Patent Office (EPO)A4
US9217040B2United States of AmericaB2
US2016097776A1United States of AmericaA1
US9523695B2United States of AmericaB2
EP2663579B1European Patent Office (EPO)B1
PT2663579TPortugalT
DK2663579T3DenmarkT3
US2017248585A1United States of AmericaA1
ES2634098T3SpainT3
PL2663579T3PolandT3
EP3252076A1European Patent Office (EPO)A1
US9933434B2United States of AmericaB2
HUE035281T2HungaryT2
US2018348232A1United States of AmericaA1
CA2981662CCanadaC
EP3252076B1European Patent Office (EPO)B1
DK3252076T3DenmarkT3
EP3604339A1European Patent Office (EPO)A1
US10627409B2United States of AmericaB2
ES2758533T3SpainT3
US2020309785A1United States of AmericaA1
US10900973B2United States of AmericaB2
EP3604339B1European Patent Office (EPO)B1
DK3604339T3DenmarkT3
PT3604339TPortugalT
US2021208158A1United States of AmericaA1
HUE053720T2HungaryT2
EP3885366A2European Patent Office (EPO)A2
ES2865068T3SpainT3
PL3604339T3This recordPolandT3
EP3885366A3European Patent Office (EPO)A3
US11536727B2United States of AmericaB2
US2023341412A1United States of AmericaA1
US12222355B2United States of AmericaB2